| abstract |
HDAC and / or CDK inhibitors may have a therapeutic effect on a wide range of patients. There is a continuing need for the development of new inhibitors that provide adequate therapeutic effects for various medical conditions involving HDAC and / or CDK activity. According to the present invention, a compound of general formula (I) having a histone deacetylase (HDAC) inhibitory activity and / or a cyclin dependent kinase (CDK) inhibitory activity, a pharmaceutical composition containing the compound, and a compound thereof are used. Useful methods for treating diseases are provided. |